Lv1
50 积分 2024-02-24 加入
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder
2天前
已完结
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
6天前
已完结
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
6天前
已完结
An Fc-Engineered CD19 Antibody Engages Macrophages and Is Effective in Xenograft Models of Pediatric Acute Lymphoblastic Leukemia
6天前
已关闭
Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells
19天前
已完结
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer
21天前
已完结
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2
22天前
已完结
Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2
23天前
已完结
Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient–Derived Xenografts and Mesothelin as a Biomarker of Tumor Response
23天前
已完结
Engineered Extracellular Vesicles Expressing Siglec‐10 Camouflaged AIE Photosensitizer to Reprogram Macrophages to Active M1 Phenotype and Present Tumor‐Associated Antigens for Photodynamic Immunotherapy
1个月前
已完结
皖公网安备34019202002308
